EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of NPPB for Recovery Post Ventricular Assist Device in Paediatric Dilated Cardiomyopathy: Single-Cell Multiomics

Yosuke Kugo, Takuji Kawamura, Akima Harada, Yuji Tominaga, Kenji Miki, Hidekazu Ishida, Takayoshi Ueno, Shigeru Miyagawa iD

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Yosuke Kugo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Graduate School of Medicine Faculty of Medicine, The University of Osaka, Suita, Japan. Hauptthemen laut MEDLINE: Heart-Assist Devices, Cardiomyopathy, Dilated, Ventricular Function, Left, Recovery of Function. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Paediatric heart transplantation requires lifelong immunosuppression, highlighting the need for recovery-oriented strategies. A subset of children with dilated cardiomyopathy (DCM) recovers left ventricular (LV) function after LV assist device (LVAD) implantation, allowing for device explantation. We aimed to identify factors associated with LV functional recovery using single-nucleus multiomics analysis of LV tissue collected at LVAD implantation.

Methods

We included children with idiopathic DCM who underwent LVAD implantation between 2013 and 2023. Patients who achieved device explantation and medical stabilization were classified as the recovery group while those who required transplantation or died were classified as the non-recovery group. Single-nucleus RNA and ATAC sequencing were performed in six representative cases. Differential gene expression, chromatin accessibility and gene ontology (GO) enrichment analyses were conducted. Candidate markers were validated histologically and serologically in the full cohort.

Results

Twenty-five cases were included (non-recovery, n = 15; recovery, n = 10). Age at LVAD implantation [median (range)] was 0.9 (0.1–4.6) versus 0.8 (0.3–5.6) years (P = 0.8), sex 27% versus 30% male (P > 0.9) and body weight 5.9 (3.8–14.0) versus 7.5 (5.0–26.0) kg (P = 0.049). LV ejection fraction at implantation was similar (24 (10–44) % vs. 15 (10–25) %, P = 0.2). RNA sequencing showed elevated NPPB, MYL7 and PCDH9 in recovery-group cardiomyocytes, with NPPB highest expression [baseMean = 16 305; log2Fold Change (FC) = 2.698; P < 0.001] and an accessible chromatin peak at its locus (log2FC = 1.17; P < 0.01). GO analysis indicated enrichment in apoptosis-related pathways (coefficient = 1.77, P = 0.023). Serum brain natriuretic peptide (BNP), the protein product of NPPB, was significantly higher in the recovery group at implantation [732 (372–4179) vs. 3048 (642–6032) pg/mL, P = 0.04] as was the proportion of non-apoptotic cardiomyocytes [0.21 (0.02–0.37) vs. 0.37 (0.19–0.48), P = 0.03].

Conclusions

Elevated NPPB expression and BNP levels at LVAD implantation are associated with LV recovery in paediatric DCM. These findings support an anti-apoptotic role of BNP in successful bridge-to-recovery outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesCardiomyopathy, DilatedVentricular Function, LeftRecovery of FunctionHumansMaleFemaleChild, PreschoolInfantChildSingle-Cell AnalysisRetrospective StudiesFollow-Up StudiesMultiomics

Stichwörter der Autor:innen

apoptosisbridge to recoverydilated cardiomyopathyleft ventricular assist devicenatriuretic peptidespaediatricsingle‐cell multiomics

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Graduate School of Medicine Faculty of Medicine, The University of Osaka, Suita, Japan.
  • Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Premium Research Institute for Human Metaverse Medicine, The University of Osaka, Suita, Japan.
  • Department of Pediatrics, Graduate School of Medicine Faculty of Medicine, The University of Osaka, Suita, Japan.
  • Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Suita, Japan.

ORCID-Profile: Shigeru Miyagawa

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kugo, Y., Kawamura, T., Harada, A., Tominaga, Y., Miki, K., Ishida, H., Ueno, T., & Miyagawa, S. (2025). Role of NPPB for Recovery Post Ventricular Assist Device in Paediatric Dilated Cardiomyopathy: Single-Cell Multiomics. ESC Heart Failure. https://doi.org/10.1002/ehf2.15430

Vancouver

Kugo Y, Kawamura T, Harada A, Tominaga Y, Miki K, Ishida H, et al. Role of NPPB for Recovery Post Ventricular Assist Device in Paediatric Dilated Cardiomyopathy: Single-Cell Multiomics. ESC Heart Failure. 2025. doi:10.1002/ehf2.15430

BibTeX
@article{Kugo2025,
  author = {Kugo, Yosuke and Kawamura, Takuji and Harada, Akima and Tominaga, Yuji and Miki, Kenji and Ishida, Hidekazu and Ueno, Takayoshi and Miyagawa, Shigeru},
  title = {Role of NPPB for Recovery Post Ventricular Assist Device in Paediatric Dilated Cardiomyopathy: Single-Cell Multiomics},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15430}
}
Kostenlos starten →